Capstone Therapeutics (CAPS) Will Provide an Operating Update and Announces First Quarter 2013 Financial Results
5/15/2013 9:01:10 AM
More...
|
Capstone Therapeutics (CAPS) to Hold Operating Update Conference Call
5/8/2013 9:16:05 AM
More...
|
Capstone Therapeutics (CAPS) Will Provide an Operating Update and Announces 2012 Financial Results
3/14/2013 11:00:31 AM
More...
|
Capstone Therapeutics (CAPS) Release: Apolipoprotein E Mimetic Peptide AEM-28 Granted Orphan Drug Designation for the Treatment of Homozygous Familial Hypercholesterolemia
12/7/2012 9:44:49 AM
More...
|
Capstone Therapeutics (CAPS) to Hold Quarterly Update Conference Call
11/5/2012 9:37:06 AM
More...
|
Capstone Therapeutics (CAPS) Enters into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call
8/6/2012 9:19:11 AM
More...
|
Capstone Therapeutics (CAPS) Provides Operating Update and Announces 2011 Financial Results
3/21/2012 10:36:41 AM
More...
|
Capstone Therapeutics (CAPS) Halts Development of Principal Drug Candidate, Cuts Half of Board Members to Preserve Cash
1/20/2012 8:09:17 AM
More...
|
Capstone Therapeutics (CAPS) Announces Plan to Preserve Cash During Ongoing Partnering Efforts, Cutting Staff Down to 4
10/14/2011 8:35:45 AM
More...
|
Capstone Therapeutics (CAPS) to Hold Quarterly Update Conference Call
8/23/2011 10:08:38 AM
More...
|
|